Identity
- Security key
- 11964
- Ticker
- ASND
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-04-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ASND
Detail
Enriched 2026-08-14 20:47
- Market cap
- $16,756,344,351.8
- Shares outstanding (class)
- —
- Shares outstanding (weighted)
- 65,592,830
- SIC
- —
- Employees
- 1,189
- Location
- —
- Homepage
- https://www.ascendispharma.com
- Description
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Market cap and share counts drift.